GB0013927A
GB0013927D0
(en)
|
2000-06-08 |
2000-06-08 |
Combination therapy
|
EEP200200565A
EE200200565A
(en)
|
2000-03-31 |
2001-02-27 |
Combination therapy with vascular adverse effects
|
SK1391-2002A
SK13912002A3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
NZ521025A
NZ521025A
(en)
|
2000-03-31 |
2001-03-27 |
Combination and split dose therapies of ZD6126 and either a platinum anti-tumor agent, i.e. cisplatin, carboplatin oxaliplatin or ZD0473, a taxane, i.e. paclitaxel or docetaxel, or ionising radiation with vascular damaging activity
|
RU2002129097/15A
RU2268729C2
(en)
|
2000-03-31 |
2001-03-27 |
Combined therapies using of angiogenesis damaging activity
|
MXPA02009604A
MXPA02009604A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity.
|
KR1020027013061A
KR20020087456A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
CN01807444A
CN1430515A
(en)
|
2000-03-31 |
2001-03-27 |
Divided dose therapies with vascular damaging activity
|
EP01915490A
EP1272199B1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
PCT/GB2001/001317
WO2001074368A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
BR0109672-9A
BR0109672A
(en)
|
2000-03-31 |
2001-03-27 |
Use of zd6126 or a pharmaceutically acceptable salt thereof and one of: a plantin antitumor agent and a taxane, pharmaceutical composition, combination product, kit, and method for producing a vascularly damaging effect on a warm-blooded animal
|
DK01915490T
DK1272199T3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damage activity
|
US10/240,213
US6906048B2
(en)
|
2000-03-31 |
2001-03-27 |
N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity
|
ES01915490T
ES2236199T3
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VASCULAR DETERIORATION ACTIVITY.
|
HU0300290A
HUP0300290A3
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
CA002402539A
CA2402539A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
JP2001572111A
JP2003528920A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapy with vascular damaging activity
|
DE60108489T
DE60108489T2
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VULNERABLE ACTIVITY
|
AU2001242581A
AU2001242581B2
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
PL01366379A
PL366379A1
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
IL15162801A
IL151628A0
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
AT01915490T
ATE287267T1
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY
|
AU4258101A
AU4258101A
(en)
|
2000-03-31 |
2001-03-27 |
Combination therapies with vascular damaging activity
|
CZ20023228A
CZ20023228A3
(en)
|
2000-03-31 |
2001-03-27 |
Pharmaceutical preparations used for inducing blood vessel-damaging effect
|
SI200130311T
SI1272199T1
(en)
|
2000-03-31 |
2001-03-27 |
|
PT01915490T
PT1272199E
(en)
|
2000-03-31 |
2001-03-27 |
COMBINATION THERAPIES WITH LESAO VASCULAR ACTIVITY
|
IS6558A
IS6558A
(en)
|
2000-03-31 |
2002-09-20 |
Mixed disease treatment with vasoconstrictor
|
NO20024646A
NO20024646L
(en)
|
2000-03-31 |
2002-09-27 |
Combination therapies with vasculature-damaging activity
|
US10/994,639
US20050107346A1
(en)
|
2000-03-21 |
2004-11-23 |
N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity
|